Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Intangibles: 2024

Historic Intangibles for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $15.6 million.

  • Day One Biopharmaceuticals' Intangibles rose 16.03% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 16.03%. This contributed to the annual value of $15.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Intangibles of $15.6 million as of FY2024.
  • Day One Biopharmaceuticals' 5-year Intangibles high stood at $15.6 million for FY2024, and its period low was $15.6 million during FY2024.
  • Moreover, its 1-year median value for Intangibles was $15.6 million (2024), whereas its average is $15.6 million.